Liposome-Encapsulated Anti-inflammatory Proteins for Targeted Delivery to the Placenta to Treat Fetal Growth Restriction. (2024)
Attributed to:
Developing personalized nanotherapies to target placental abnormalities causing fetal growth restriction
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1007/978-1-0716-3495-0_14
PubMed Identifier: 38019400
Publication URI: http://europepmc.org/abstract/MED/38019400
Type: Journal Article/Review
Volume: 2728
Parent Publication: Methods in molecular biology (Clifton, N.J.)
ISSN: 1064-3745